AAAAAA
Results:
1-11
|
Results: 11
Authors:
DEGARDIN M
OLIVEIRA J
GEOFFROIS L
ROLLAND F
ARMAND JP
BASTIT P
CHAUVERGNE J
FARGEOT P
VANGLABBEKE M
LENTZ MA
TRESCA P
BOUDILLET J
FUMOLEAU P
CAPPELAERE P
Citation: M. Degardin et al., AN EORTC-ECSG PHASE-II STUDY OF VINORELBINE IN PATIENTS WITH RECURRENT AND OR METASTATIC SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK/, Annals of oncology, 9(10), 1998, pp. 1103-1107
Authors:
DEGARDIN M
BASTIT P
ROLLAND F
ARMAND JP
CHEVALLIER B
VANGLABBEKE M
BOUDILLET J
TRESCA P
Citation: M. Degardin et al., PHASE-II STUDY OF VINORELBINE (NVB) IN PATIENTS WITH METASTATIC AND OR RECURRENT SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK (SCCHN)/, European journal of cancer, 33, 1997, pp. 843-843
Authors:
DEGARDIN M
CAPPELAERE P
KRAKOWSKI I
FARGEOT P
CUPISSOL D
BRIENZA S
Citation: M. Degardin et al., PHASE-II TRIAL OF OXALIPLATIN (L-OHP) IN ADVANCED, RECURRENT AND OR METASTATIC SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK/, European journal of cancer. Part B, Oral oncology, 32B(4), 1996, pp. 278-279
Authors:
FAUSER AA
BLEIBERG H
CHEVALLIER B
FAVRE R
FABBRO M
NOBLE A
CUPISSOL D
DEGARDIN M
CAPPELAERE P
SPAETH D
CLAVERIE N
Citation: Aa. Fauser et al., A DOUBLE-BLIND, RANDOMIZED, PARALLEL STUDY OF IV DOLASETRON MESILATE VERSUS IV METOCLOPRAMIDE IN PATIENTS RECEIVING MODERATELY EMETOGENIC CHEMOTHERAPY, The Cancer journal, 9(4), 1996, pp. 196-202
Authors:
PECHERSTORFER M
HERRMANN Z
BODY JJ
MANEGOLD C
DEGARDIN M
CLEMENS MR
THURLIMANN B
TUBIANAHULIN M
STEINHAUER EU
VANEIJKEREN M
HUSS HJ
THIEBAUD D
Citation: M. Pecherstorfer et al., RANDOMIZED PHASE-II TRIAL COMPARING DIFFERENT DOSES OF THE BISPHOSPHONATE IBANDRONATE IN THE TREATMENT OF HYPERCALCEMIA OF MALIGNANCY, Journal of clinical oncology, 14(1), 1996, pp. 268-276
Authors:
CAPPELAERE P
LENTZ MA
DEGARDIN M
CHAUVERGNE J
MAYER F
CHOLLET P
CHEVALLIER B
Citation: P. Cappelaere et al., PHASE-II STUDY OF CYSTEMUSTINE IN ADVANCED HEAD AND NECK-CANCER - A TRIAL OF THE EORTC CLINICAL SCREENING GROUP, European journal of cancer. Part B, Oral oncology, 31B(2), 1995, pp. 151-152
Authors:
DEGARDIN M
CAPPELAERE P
CATY A
LEFEBVRE JL
Citation: M. Degardin et al., M-VAC CHEMOTHERAPY AND GM-CSF IN ADVANCED, RECURRENT AND OR METASTATIC SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK (SCCHN)/, European journal of cancer, 31A, 1995, pp. 438-438
Authors:
DEGARDIN M
ARMAND JP
CHEVALLIER B
CAPPELAERE P
LENTZ MA
DAVID M
ROCHE H
Citation: M. Degardin et al., A CLINICAL SCREENING COOPERATIVE GROUP PHASE-II EVALUATION OF LOBAPLATIN (ASTA D-19466) IN ADVANCED HEAD AND NECK-CANCER, Investigational new drugs, 13(3), 1995, pp. 253-255
Authors:
DEGARDIN M
NGUYEN M
BEAURIN D
LESOIN A
FOURNIER C
LEFEBVRE JL
CAPPELAERE P
Citation: M. Degardin et al., HYPERCALCEMIA AND SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK - FREQUENCY AND PROGNOSIS, Bulletin du cancer, 82(11), 1995, pp. 975-980
Authors:
DEGARDIN M
DOMENGE C
CAPPELAERE P
LUBOINSKI B
NAVARRETE MS
SCOTT JE
LEFEBVRE JL
Citation: M. Degardin et al., A PHASE-II STUDY OF PIRITREXIM IN PATIENTS WITH ADVANCED SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK, European journal of cancer, 30A(7), 1994, pp. 1044-1045
Authors:
DEGARDIN M
BONNETERRE J
HECQUET B
PION JM
ADENIS A
HORNER D
DEMAILLE A
Citation: M. Degardin et al., VINORELBINE (NAVELBINE) AS A SALVAGE TREATMENT FOR ADVANCED BREAST-CANCER, Annals of oncology, 5(5), 1994, pp. 423-426
Risultati:
1-11
|